Close X
Get more out of WDDTY.com
by joining the site for free
Free 17-point plan to great health
Twice weekly e-news bulletins
Access to our News, Forums and Blogs
Sign up for free and claim your
17-point plan to great health
Free 17-point plan to great health

Twice weekly e-news bulletins

Access to our News, Forums and Blogs
OR

If you want to read our in-depth research articles or
have our amazing magazine delivered to your home
each month, then you have to pay.


Click here if you're interested
Helping you make better health choices

In shops now or delivered to your home from only £3.50 an issue!

Subscribe!

Ticlid

About the author: 

There seems to be growing interest in Ticlid (ticlopidine hydrochloride) which is designed to reduce the risk of stroke among patients at risk

There seems to be growing interest in Ticlid (ticlopidine hydrochloride) which is designed to reduce the risk of stroke among patients at risk.

In America, Geneva Pharmaceuticals, the distributor of Ticlid, has issued a "Dear Doctor. . ." letter but, significantly, has addressed it to "Dear concerned health professional".

The concern seems to be caused by the large number of side effects, including severe and fatal blood disorders, that the drug can cause. The most dangerous is the sudden drop in the white blood cell count, a condition called neutropenia, which early trials indicated could affect around 2.4 per cent of patients.

Ticlid is, in any event, only supposed to be given to those who cannot tolerate aspirin, but Geneva Pharmaceuticals is now advising doctors to first screen patients for any possible adverse reaction before prescribing.

As Ticlid causes an adverse reaction in 60 per cent of all users, the chances of it being prescribed have probably just dropped dramatically. The most common reaction is diarrhoea, which affects more than 12 per cent of patients, followed by nausea and dyspepsia (both 7 per cent) while over 5 per cent develop a rash. Rarer, but more serious, conditions caused by the drug have included anaemia, hepatitis, kidney failure and lupus.

But the most worrying side effectseems to be neutropenia. It can often be fatal if undetected and untreated because it lowers the body's natural resistance to disease. The drug manufacturer Roche Laboratories urges doctors to take blood tests every fortnight for the first three months, the time when neutropenia is most likely to occur.

And, concludes Geneva Pharmaceutical's letter, if your patient does die, please tell the authorities. OK?


Where did it start?

Scientifically proven alternatives to conventional medicine

You may also be interested in...

Latest Tweet

About

Since 1989, WDDTY has provided thousands of resources on how to beat asthma, arthritis, depression and many other chronic conditions.

Start by looking in our fully searchable database, active and friendly community forums and the latest health news.

Positive SSL Wildcard

Facebook Twitter

Most Popular Health Website of the Year 2014

© 2010 - 2017 WDDTY Publishing Ltd.
All Rights Reserved